Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaohui Fang

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Innovation (Cambridge (Mass.))|November 8, 2021
Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, ChinaQianyun Liu, Qing Xiong, Fanghua Mei, et al.
Nature Communications|March 23, 2021
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19Jun Wu, Boyun Liang, Cunrong Chen, et al.
Plos Biology|May 7, 2021
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopesDan Fu, Guangshun Zhang, Yuhui Wang, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Innovation (Cambridge (Mass.))|November 8, 2021
Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, ChinaQianyun Liu, Qing Xiong, Fanghua Mei, et al.
Nature Communications|March 23, 2021
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19Jun Wu, Boyun Liang, Cunrong Chen, et al.
Plos Biology|May 7, 2021
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopesDan Fu, Guangshun Zhang, Yuhui Wang, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 4